70 likes | 144 Views
The rising prevalence of autoimmune diseases and consequent increase in healthcare expenditure globally are the major factors driving the autoimmune disease diagnostics market.
E N D
Your Catalyst To a Lucrative Business Autoimmune Disease Diagnostics Market Research Report - Industry Analysis, Size and Forecast to 2020 | Hexa Research “The rising prevalence of autoimmune diseases and consequent increase in healthcare expenditure globally are the major factors driving the autoimmune disease diagnostics market.” Factors that propel the Global Autoimmune Disease Diagnostics Market are rising cases of autoimmune diseases and surging healthcare expenditure. Encouraging governmental policies regarding autoimmune diagnostics & research has a positive impact on market demand. Autoimmune diseases are a key cause of women deaths worldwide. Furthermore, active awareness initiatives regarding diagnosis of diseases may contribute significantly to the global industry during the forecast period (2012 to 2020). A large number of laboratories have begun installing equipment that can carry out several tests simultaneously and deliver quick results. Automation in laboratory procedures ensures greater efficiency. The worldwide autoimmune disease diagnostics market is categorized on the basis of products and regions. On the basis of products, there are two key segments, namely, localized disease diagnostics and systemic autoimmune disease diagnostics. Owing to greater patient awareness and huge procedure volumes, the localized disease diagnostics segment held the highest share in 2013. Browse Details of Report@ https://www.hexaresearch.com/research-report/autoimmune-disease-diagnostics-industry Follow Us:
Your Catalyst To a Lucrative Business A number of unmet medical needs in type 1 diabetics is a key factor that drives this segment. The systemic autoimmune disease diagnostics segment mainly involves the diagnosis of diseases, such as rheumatoid arthritis, lupus erythematosus (SLE), and Ankylosing spondylitis. The rheumatoid arthritis segment holds the highest share in the industry because it is the most frequently occurring inflammatory ailment worldwide. It is led by product innovation. On the basis of geographies, the global autoimmune disease diagnostics market is divided into Europe, Asia Pacific, North America, and Rest of the World. In revenue terms, North America was the largest market in 2013. This region is propelled by a well developed healthcare infrastructure and positive government initiatives, such as the Affordable Care Act and Patient Protection Act. In terms of yearly expenditure on autoimmune disease diagnostics, North America ranks number one in the overall industry. Moreover, surging per capita spending on healthcare is projected to significantly drive regional growth till 2020. Europe, the second largest market after North America, is propelled by technological advancements and high cases of autoimmune diseases. These technological developments are mainly observed in portable diagnostics equipment and biomarkers. Europe may derive much of its demand for autoimmune disease diagnostics from Eastern Europe. Being a highly consolidated one, the global market for autoimmune disease diagnostics market witnesses frequent mergers & acquisitions. It is a moderately competitive industry that is led by innovations and price wars. Key competitors in the global industry are Bio Rad, Crescendo Bioscience, Roche Diagnostics, Quest Diagnostics, and Abbott Diagnostics. In October 2016, IQuity, a diagnostics technology company launched the IQIsolate® technology. This technology helps identify autoimmune anomalies during its early stages. It analyzes the RNA structures in blood samples. Interestingly, IQIsolate® has exhibited ninety percent accuracy in three key medical specialties, namely, rheumatology, gastroenterology, and neurology. The company asserts that its technology can significantly reduce the diagnostics processes of complex autoimmune diseases. It can also differentiate between diseases that show similar symptoms. A striking feature of IQuity’s blood based diagnostic technology is that it helps providers & physicians confirm other types of autoimmune anomalies within a week. It is expected to gradually commercialize newer test panels that focus on rheumatology and gastroenterology. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry Follow Us:
Your Catalyst To a Lucrative Business Table of Content of Autoimmune Disease Diagnostics Market Chapter 1 Executive Summary Chapter 2 Autoimmune Disease Diagnostics Industry Outlook 2.1 Market Segmentation 2.2 Market Size and Growth Prospects 2.3 Autoimmune disease diagnostics - Market dynamics 2.3.1 Market Driver Analysis 2.3.1.2 Presence of research funding programs 2.3.1.4 Growing patient awareness levels 2.3.1.5 Technological innovation in the form of lab automation 2.3.2 Market Restraint Analysis 2.3.2.1 Slow diagnostic result turnaround times and lack of skilled healthcare practitioners 2.4 Key Opportunities Prioritized 2.5 Industry Analysis - Porter’s 2.6 Autoimmune Disease Diagnostics - PESTEL Analysis Chapter 3 Autoimmune Disease Diagnostics Product Outlook 3.1 Autoimmune disease diagnostics market share by product, 2013 & 2020 3.2 Systemic Autoimmune disease diagnostics 3.2.1 Systemic autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 3.2.2 Rheumatoid arthritis diagnostics market, 2012 - 2020 (USD Million) 3.2.3 Ankylosing spondylitis diagnostics market, 2012 - 2020 (USD Million) 3.2.4 Systemic lupus erythematosus (SLE) diagnostics market, 2012 - 2020 (USD Million) 3.3 Localized disease diagnostics 3.3.1 Localized disease diagnostics market, 2012 - 2020 (USD Million) Chapter 4 Autoimmune Disease Diagnostics Regional Outlook 4.1 Autoimmune disease diagnostics market share by region, 2013 & 2020 4.2 North America 4.2.1 North America autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 4.2.2 U.S. autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 4.2.3 Canada autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 4.3 Europe Follow Us:
Your Catalyst To a Lucrative Business 4.3.1 Europe autoimmune disease diagnostics market, 2012-2020 (USD Million) 4.3.2 Germany autoimmune disease diagnostics market, 2012 - 2020 (USD Million) 4.3.3 UK autoimmune disease diagnostics market, 2012-2020 (USD Million) 4.4 Asia Pacific 4.4.1 Asia Pacific autoimmune disease diagnostics market, 2012-2020 (USD Million) 4.4.2 China autoimmune disease diagnostics market, 2012-2020 (USD Million) 4.4.3 Japan autoimmune disease diagnostics market, 2012-2020 (USD Million) 4.5 RoW 4.5.1 RoW autoimmune disease diagnostics market, 2012-2020 (USD Million) 4.5.2 Brazil autoimmune disease diagnostics market, 2012-2020 (USD Million) Chapter 5 Competitive Landscape 5.1 Abbott Laboratories 5.1.1 Company Overview 5.1.2 Financial Performance 5.1.3 Product Benchmarking 5.2 Siemens Healthcare 5.2.1 Company Overview 5.2.2 Financial Performance 5.2.3 Product Benchmarking 5.2.4 Strategic Initiatives 5.3 Roche Diagnostics 5.3.1 Company Overview 5.3.2 Financial Performance 5.3.3 Product Benchmarking 5.4 Beckman Coulter Inc. 5.4.1 Company Overview 5.4.2 Financial Performance 5.4.3 Product Benchmarking 5.5 SQI Diagnostics Inc. 5.5.1 Company Overview 5.5.2 Financial Performance 5.5.3 Product Benchmarking 5.5.4 Strategic Initiatives 5.6 EUROIMMUN 5.6.1 Company Overview Follow Us:
Your Catalyst To a Lucrative Business 5.6.2 Financial Performance 5.6.3 Product Benchmarking 5.6.4 Strategic Initiatives 5.7 AESKU DIAGNOSTICS 5.7.1 Company Overview 5.7.2 Financial Performance 5.7.3 Product Benchmarking 5.7.4 Strategic Initiatives 5.8 INOVA Diagnostics Inc. 5.8.1 Company Overview 5.8.2 Financial Performance 5.8.3 Product Benchmarking 5.8.4 Strategic Initiatives 5.9 Crescendo Bioscience Inc 5.9.1 Company Overview 5.9.2 Financial Performance 5.9.3 Product Benchmarking 5.9.4 Strategic Initiatives 5.10 bioMerieux SA. 5.10.1 Company Overview 5.10.2 Financial Performance 5.10.3 Product Benchmarking 5.10.4 Strategic Initiatives 5.11 Bio-Rad Laboratories Inc. 5.11.1 Company Overview 5.11.2 Financial Performance 5.11.3 Product Benchmarking 5.11.4 Strategic Initiatives 5.12 Hemagen Diagnostics Inc. 5.12.1 Company Overview 5.12.2 Financial Performance 5.12.3 Product Benchmarking 5.13 Quest Diagnostics. 5.13.1 Company Overview 5.13.2 Financial Performance 5.13.3 Product Benchmarking Follow Us:
Your Catalyst To a Lucrative Business 5.13.4 Strategic Initiatives Chapter 6 Methodology and Scope 6.1 Research Methodology 6.2 Research Scope & Assumptions 6.3 List of Data Sources Follow Us:
Your Catalyst To a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit Our Blog - hexaresearch1.blogspot.com Follow Us: